239 related articles for article (PubMed ID: 30197006)
21. Cathepsin S promotes the development of pulmonary arterial hypertension.
Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
[TBL] [Abstract][Full Text] [Related]
22. The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.
Green DE; Murphy TC; Kang BY; Kleinhenz JM; Szyndralewiez C; Page P; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):718-26. PubMed ID: 22904198
[TBL] [Abstract][Full Text] [Related]
23. Prostanoid EP
Li HH; Hsu HH; Chang GJ; Chen IC; Ho WJ; Hsu PC; Chen WJ; Pang JS; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L349-L359. PubMed ID: 29146573
[TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.
Nisbet RE; Bland JM; Kleinhenz DJ; Mitchell PO; Walp ER; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2010 Apr; 42(4):482-90. PubMed ID: 19520921
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs.
Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.
Green DE; Murphy TC; Kang BY; Bedi B; Yuan Z; Sadikot RT; Hart CM
Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L371-L383. PubMed ID: 28522568
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β.
Deng B; Du J; Hu R; Wang AP; Wu WH; Hu CP; Li YJ; Li XH
Life Sci; 2016 Feb; 147():117-24. PubMed ID: 26827991
[TBL] [Abstract][Full Text] [Related]
29. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
[TBL] [Abstract][Full Text] [Related]
30. FGF21 attenuates hypoxia‑induced dysfunction and inflammation in HPAECs via the microRNA‑27b‑mediated PPARγ pathway.
Yao D; He Q; Sun J; Cai L; Wei J; Cai G; Liu J; Lin Y; Wang L; Huang X
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907846
[TBL] [Abstract][Full Text] [Related]
31. Mitofusin 2 Downregulation Triggers Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis Imbalance in Rats With Hypoxic Pulmonary Hypertension Via the PI3K/Akt and Mitochondrial Apoptosis Pathways.
Fang X; Chen X; Zhong G; Chen Q; Hu C
J Cardiovasc Pharmacol; 2016 Feb; 67(2):164-74. PubMed ID: 26485208
[TBL] [Abstract][Full Text] [Related]
32. Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension.
Smith KA; Voiriot G; Tang H; Fraidenburg DR; Song S; Yamamura H; Yamamura A; Guo Q; Wan J; Pohl NM; Tauseef M; Bodmer R; Ocorr K; Thistlethwaite PA; Haddad GG; Powell FL; Makino A; Mehta D; Yuan JX
Am J Respir Cell Mol Biol; 2015 Sep; 53(3):355-67. PubMed ID: 25569851
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature.
Kang BY; Park KK; Green DE; Bijli KM; Searles CD; Sutliff RL; Hart CM
PLoS One; 2013; 8(11):e79503. PubMed ID: 24244514
[TBL] [Abstract][Full Text] [Related]
34. Iptakalim induces mitochondria-dependent apoptosis in hypoxic rat pulmonary arterial smooth muscle cells.
Xu Q; Wu X; Li Y; Kong H; Jin Y; Xie W; Wang H
Biomed Pharmacother; 2016 Dec; 84():773-779. PubMed ID: 27718461
[TBL] [Abstract][Full Text] [Related]
35. Egr-1 mediates leptin-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells.
Xie X; Li S; Zhu Y; Liu L; Ke R; Wang J; Yan X; Yang L; Gao L; Zang W; Li M
Mol Biol Cell; 2018 Feb; 29(3):356-362. PubMed ID: 29212876
[TBL] [Abstract][Full Text] [Related]
36. Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells.
Jin H; Wang Y; Zhou L; Liu L; Zhang P; Deng W; Yuan Y
J Pineal Res; 2014 Nov; 57(4):442-50. PubMed ID: 25251287
[TBL] [Abstract][Full Text] [Related]
37. Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells.
Blum JI; Bijli KM; Murphy TC; Kleinhenz JM; Hart CM
Am J Med Sci; 2016 Jul; 352(1):71-9. PubMed ID: 27432037
[TBL] [Abstract][Full Text] [Related]
38. Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxis.
Zhang S; Liu J; Zheng K; Chen L; Sun Y; Yao Z; Sun Y; Lin Y; Lin K; Yuan L
Vascul Pharmacol; 2021 Feb; 136():106820. PubMed ID: 33238205
[TBL] [Abstract][Full Text] [Related]
39. 4-Terpineol attenuates pulmonary vascular remodeling via suppressing PI3K/Akt signaling pathway in hypoxia-induced pulmonary hypertension rats.
Gu C; Yang Z; Su S; Ma K; Nan X; Li Z; Lu D
Toxicol Appl Pharmacol; 2023 Aug; 473():116596. PubMed ID: 37328117
[TBL] [Abstract][Full Text] [Related]
40. Hypercapnia downregulates hypoxia-induced lysyl oxidase expression in pulmonary artery smooth muscle cells via inhibiting transforming growth factor β
Xia XD; Peng YP; Lei D; Chen WQ
Cell Biochem Funct; 2019 Apr; 37(3):193-202. PubMed ID: 30917408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
